BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28566381)

  • 1. Hepatitis C Virus Subverts Human Choline Kinase-α To Bridge Phosphatidylinositol-4-Kinase IIIα (PI4KIIIα) and NS5A and Upregulates PI4KIIIα Activation, Thereby Promoting the Translocation of the Ternary Complex to the Endoplasmic Reticulum for Viral Replication.
    Wong MT; Chen SS
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation.
    Wong MT; Chen SS
    J Virol; 2016 Oct; 90(20):9075-95. PubMed ID: 27489281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of functional domains of the lipid kinase phosphatidylinositol 4-kinase type III alpha involved in enzymatic activity and hepatitis C virus replication.
    Harak C; Radujkovic D; Taveneau C; Reiss S; Klein R; Bressanelli S; Lohmann V
    J Virol; 2014 Sep; 88(17):9909-26. PubMed ID: 24920820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5A.
    Reiss S; Harak C; Romero-Brey I; Radujkovic D; Klein R; Ruggieri A; Rebhan I; Bartenschlager R; Lohmann V
    PLoS Pathog; 2013 May; 9(5):e1003359. PubMed ID: 23675303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity.
    Bianco A; Reghellin V; Donnici L; Fenu S; Alvarez R; Baruffa C; Peri F; Pagani M; Abrignani S; Neddermann P; De Francesco R
    PLoS Pathog; 2012; 8(3):e1002576. PubMed ID: 22412376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase IIIα complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes.
    Reghellin V; Donnici L; Fenu S; Berno V; Calabrese V; Pagani M; Abrignani S; Peri F; De Francesco R; Neddermann P
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7128-40. PubMed ID: 25224012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type IIIalpha and regulates viral propagation.
    Lim YS; Hwang SB
    J Biol Chem; 2011 Apr; 286(13):11290-8. PubMed ID: 21297162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment.
    Reiss S; Rebhan I; Backes P; Romero-Brey I; Erfle H; Matula P; Kaderali L; Poenisch M; Blankenburg H; Hiet MS; Longerich T; Diehl S; Ramirez F; Balla T; Rohr K; Kaul A; Bühler S; Pepperkok R; Lengauer T; Albrecht M; Eils R; Schirmacher P; Lohmann V; Bartenschlager R
    Cell Host Microbe; 2011 Jan; 9(1):32-45. PubMed ID: 21238945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of phosphatidylinositol-4-kinase IIIα as a hepatitis C virus drug target.
    Vaillancourt FH; Brault M; Pilote L; Uyttersprot N; Gaillard ET; Stoltz JH; Knight BL; Pantages L; McFarland M; Breitfelder S; Chiu TT; Mahrouche L; Faucher AM; Cartier M; Cordingley MG; Bethell RC; Jiang H; White PW; Kukolj G
    J Virol; 2012 Nov; 86(21):11595-607. PubMed ID: 22896614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication.
    Berger KL; Kelly SM; Jordan TX; Tartell MA; Randall G
    J Virol; 2011 Sep; 85(17):8870-83. PubMed ID: 21697487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of selective small molecule type III phosphatidylinositol 4-kinase alpha (PI4KIIIα) inhibitors as anti hepatitis C (HCV) agents.
    Leivers AL; Tallant M; Shotwell JB; Dickerson S; Leivers MR; McDonald OB; Gobel J; Creech KL; Strum SL; Mathis A; Rogers S; Moore CB; Botyanszki J
    J Med Chem; 2014 Mar; 57(5):2091-106. PubMed ID: 23944386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2.
    Khan I; Katikaneni DS; Han Q; Sanchez-Felipe L; Hanada K; Ambrose RL; Mackenzie JM; Konan KV
    J Virol; 2014 Nov; 88(21):12276-95. PubMed ID: 25122779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the phosphatidylinositol 4-kinase PI4KA in hepatitis C virus-induced host membrane rearrangement.
    Tai AW; Salloum S
    PLoS One; 2011; 6(10):e26300. PubMed ID: 22022594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus NS5A hijacks ARFGAP1 to maintain a phosphatidylinositol 4-phosphate-enriched microenvironment.
    Li H; Yang X; Yang G; Hong Z; Zhou L; Yin P; Xiao Y; Chen L; Chung RT; Zhang L
    J Virol; 2014 Jun; 88(11):5956-66. PubMed ID: 24623438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly.
    Xu S; Pei R; Guo M; Han Q; Lai J; Wang Y; Wu C; Zhou Y; Lu M; Chen X
    J Virol; 2012 Dec; 86(23):13025-37. PubMed ID: 23015700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.
    Berger C; Romero-Brey I; Radujkovic D; Terreux R; Zayas M; Paul D; Harak C; Hoppe S; Gao M; Penin F; Lohmann V; Bartenschlager R
    Gastroenterology; 2014 Nov; 147(5):1094-105.e25. PubMed ID: 25046163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between Nonstructural Proteins NS4B and NS5A Is Essential for Proper NS5A Localization and Hepatitis C Virus RNA Replication.
    Biswas A; Treadaway J; Tellinghuisen TL
    J Virol; 2016 Aug; 90(16):7205-7218. PubMed ID: 27252526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides.
    Chukkapalli V; Berger KL; Kelly SM; Thomas M; Deiters A; Randall G
    Virology; 2015 Feb; 476():168-179. PubMed ID: 25546252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI4KIII inhibitor enviroxime impedes the replication of the hepatitis C virus by inhibiting PI3 kinases.
    Delang L; Harak C; Benkheil M; Khan H; Leyssen P; Andrews M; Lohmann V; Neyts J
    J Antimicrob Chemother; 2018 Dec; 73(12):3375-3384. PubMed ID: 30219827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinexin β Interacts with Hepatitis C Virus NS5A, Modulating Its Hyperphosphorylation To Regulate Viral Propagation.
    Xiong W; Yang J; Wang M; Wang H; Rao Z; Zhong C; Xin X; Mo L; Yu S; Shen C; Zheng C
    J Virol; 2015 Jul; 89(14):7385-400. PubMed ID: 25972535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.